Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Edoxaban Versus Warfarin in Patients Undergoing a Thoracoscopic Ablation for Persistent Atrial Fibrillation

NCT04121767 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04121767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04121767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Edoxaban Versus Warfarin in Patients Undergoing a Thoracoscopic Ablation for Persistent Atrial Fibrillation
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2017
Completion date
July 10, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants and bleeding disorders, atrial fibrillation